Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer

BACKGROUND: The incidence and mortality of invasive breast cancer (IBC) are increasing annually. Hence, it is urgently needed to determine reliable biomarkers for not only monitoring curative effects, but evaluating prognosis. In present study, we aim to determine the potential role of Carboxypeptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Ranliang, Wang, Chaomin, Li, Tiantian, Hua, Jialei, Zhao, Ting, Ren, Li, Wang, Yichao, Li, Yueguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555242/
https://www.ncbi.nlm.nih.gov/pubmed/34711246
http://dx.doi.org/10.1186/s12935-021-02256-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555242/
https://www.ncbi.nlm.nih.gov/pubmed/34711246
http://dx.doi.org/10.1186/s12935-021-02256-5

Ejemplares similares